Aker BioMarine Reports That Krill Oil Continues to Boom in the Second Quarter, With A 21% Increase in Revenue

Aker BioMarine reported some days ago continued momentum in krill oil sales in the second quarter of 2026, with revenues up 21% to USD 31.5 million on solid volume growth. The company also secured a new Lysoveta contract worth USD 4 million in first-year revenues and won new Superba krill oil business ranking among the company’s largest customers. The company also informed about its revenue of USD 57.9 million in the second quarter, an increase of 5% compared to the same period last year. Adjusted EBITDA came in at 12.9 million USD, 4 percent below last year.

“Krill oil sales continued their strong momentum in the second quarter, with revenues up 21% year-over-year on solid volume growth. We are also pleased to have secured a new Lysoveta contract worth USD 4 million in first-year revenues, in addition to a large win for Superba Krill oil, important commercial milestones for our ingredient portfolio,” said the company’s CEO, Matts Johansen.

Human Health Ingredients (HHI) delivered revenue growth of 17% to 34.1 million. Sales of krill oil alone reached USD 31.5 million, an increase of 21%, driven mainly by solid volumes, with prices supported by product mix and a higher share of capsulated oil. Adjusted EBITDA for the segment increased 14% to USD 15.9 million, they explained

Production in Houston was lower in the quarter, impacting QHP sales, but stabilized to normal levels at quarter end.

Consumer Health

The company also confirmed that the Consumer Health Products (CHP) reported revenue of USD 26.4 million, a 6% decline compared with the previous year. Lang declined 4 percent on lower sales through key United States (US) retail chains, while Epion continues a marketing repositioning that is weighing on short-term revenues but is expected to be positive over time. Adjusted EBITDA came in at USD 1.1 million, reflecting lower revenues and gross profit.

Human Health Ingredients expects continued year-over-year growth and improved profits, supported by good underlying demand across multiple markets. Consumer Health Products is expected to return to modest growth.

The sale process for Understory is ongoing, with advanced discussions with one interested party. Aker BioMarine, a leading human health and nutrition company that develops sustainable marine-based ingredients, has engaged Jefferies and Houlihan Lokey as investment banks to explore strategic alternatives for the Human Health Ingredients business, working toward a transaction in 2026.

24/7 Renewable Energy Agreement

Some weeks before the release of that information, Aker BioMarine has signed a 24/7 renewable energy agreement with ENGIE, reinforcing the company’s long-term focus on operational sustainability and responsible energy sourcing. The agreement reinforces the company’s broader sustainability strategy and marks an important step in reducing the environmental footprint of its operations. Through the deal, Aker BioMarine expects to reduce Scope 2 emissions at its Houston manufacturing facility, while strengthening the transparency and precision of its climate reporting.

“Through this agreement, we expect to reduce our Scope 2 emissions, marking an important milestone in our broader sustainability journey,” commented Johansen. “ENGIE has delivered an affordable, innovative and transparent solution that allows us to match our electricity consumption for our Houston manufacturing facility with renewable power generation. The transparent data ENGIE provides strengthens our climate reporting while helping us continue delivering high-quality products with a lower environmental footprint.”

As an early mover in the biotechnology sector, Aker BioMarine is advancing its sustainability efforts through adopting site-specific Renewable Energy Certificates that link each unit of electricity consumed to power generated from named renewable energy projects. With approximately 90% of electricity consumption matched hourly with local renewable generation, the structure provides a more precise alignment between energy demand and clean supply than traditional renewable procurement models.

The agreement goes beyond traditional renewable procurement by providing around-the-clock, site-specific clean energy backed by a diversified portfolio of assets. The Impact Solar Project in Lamar County, Texas, along with other designated renewable assets, will anchor the supply that supports this agreement, they assured.

“Working with companies that have made sustainability a core part of their strategy is essential to delivering meaningful progress,” said Taymur Bunkheila, Regional VP and Retail Supply Lead for ENGIE’s US 24/7 product. “By aligning energy solutions with operational needs, we can help organizations improve transparency, strengthen accountability, and deliver measurable outcomes. This agreement demonstrates how companies can take practical steps today while building toward long-term sustainability objectives.”

More than a compliance measure, the agreement integrates energy accountability into Aker BioMarine’s day-to-day operations. The company continues to take a systematic, value-chain-wide approach to reducing emissions, prioritizing reductions that are technically and operationally feasible, while tracking progress toward its 2030 carbon intensity goal.